UA112448C2 - COMPOSITION AND METHOD OF TREATMENT OF AUTO-IMMUNE DISEASE - Google Patents

COMPOSITION AND METHOD OF TREATMENT OF AUTO-IMMUNE DISEASE

Info

Publication number
UA112448C2
UA112448C2 UAA201404226A UAA201404226A UA112448C2 UA 112448 C2 UA112448 C2 UA 112448C2 UA A201404226 A UAA201404226 A UA A201404226A UA A201404226 A UAA201404226 A UA A201404226A UA 112448 C2 UA112448 C2 UA 112448C2
Authority
UA
Ukraine
Prior art keywords
treatment
auto
composition
immune disease
immune
Prior art date
Application number
UAA201404226A
Other languages
Ukrainian (uk)
Inventor
Реза Фатхі
Патрик Лафлін МакЛін
Гарі Джеферсон Лейтон
Original Assignee
Редгіл Байофарма Лтд
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Редгіл Байофарма Лтд filed Critical Редгіл Байофарма Лтд
Priority claimed from PCT/IB2012/002252 external-priority patent/WO2013041963A2/en
Publication of UA112448C2 publication Critical patent/UA112448C2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Винахід стосується застосування композиції, що містить кларитроміцин, рифабутин і клофазамін, для виготовлення лікарського засобу для лікування розсіяного склерозу.The invention relates to the use of a composition containing clarithromycin, rifabutin and clofazamine for the manufacture of a medicament for the treatment of multiple sclerosis.

UAA201404226A 2011-09-20 2012-09-19 COMPOSITION AND METHOD OF TREATMENT OF AUTO-IMMUNE DISEASE UA112448C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161536824P 2011-09-20 2011-09-20
PCT/IB2012/002252 WO2013041963A2 (en) 2011-09-20 2012-09-19 A composition and method for treating an autoimmune disease

Publications (1)

Publication Number Publication Date
UA112448C2 true UA112448C2 (en) 2016-09-12

Family

ID=56921087

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201404226A UA112448C2 (en) 2011-09-20 2012-09-19 COMPOSITION AND METHOD OF TREATMENT OF AUTO-IMMUNE DISEASE

Country Status (1)

Country Link
UA (1) UA112448C2 (en)

Similar Documents

Publication Publication Date Title
GB201118656D0 (en) New compounds
UA116648C2 (en) FUMARATS AS A PRODUCT AND THEIR USE IN THE TREATMENT OF DIFFERENT DISEASES
UA115122C2 (en) Cd3-binding molecules capable of binding to human and non-human cd3
MX349004B (en) New compounds.
EA201200551A1 (en) PHARMACEUTICAL COMPOSITION, PHARMACEUTICAL DOSED FORM, METHODS OF THEIR PRODUCTION AND APPLICATION FOR TREATMENT
MX366899B (en) New compounds.
DOP2016000253A (en) NEW COMPOUNDS
MX356728B (en) Pharmaceutical combination for use in the treatment of diabetes type 2.
EA201591687A1 (en) INDUCTION THERAPY RITUXIMAB WITH SUBSEQUENT TREATMENT USING ACCETATE GLATIRAMER
EA201590359A1 (en) TREATMENT OF RHEUMATOID ARTHRITIS
EA201690039A1 (en) RORC2 INHIBITORS AND METHODS OF THEIR APPLICATION
GEP201706621B (en) Benzamides
BR112015031417A8 (en) pharmaceutical dosage form, pharmaceutical composition, methods for treating a patient in need of cysteamine and for preparing a dosage form
UA116889C2 (en) COMPOSITION COMPRISING A MIXTURE OF CD95-Fc ISOFORMS
NI201600070A (en) AUTOTAXIN TETRAYCLIC INHIBITORS
MX2014010433A (en) Novel crystalline form of sitagliptin sulfate.
EA201400623A1 (en) NEW 2H-INDASOLS AS ANTAGONISTS EP EPCEPTOR
MX367926B (en) Pharmaceutical composition for a sustained release of lanreotide.
EA201390616A1 (en) TREATMENT OF VIOLATIONS ASSOCIATED WITH THE MECP2 GENE
BR112013026680A2 (en) compound, method of treating an inflammatory disease and pharmaceutical composition
EA201591507A1 (en) TREATMENT OF MULTIPLE SCLEROSIS BY LACHINIMODOM
EA201491581A1 (en) ВЕЗИКУЛЯРНЫЕ КОМПОЗИЦИИ
EA201270176A1 (en) DERIVATIVES OF TAZAROTENES
EP2966087A4 (en) Antibody to peptide encoded by exon-21 of periostin, and pharmaceutical composition for prevention or treatment of inflammatory disease containing said antibody
IN2014DN03010A (en)